Institute of Digital Healthcare
The Institute of Digital Healthcare is an institute within the University of Warwick, set up in partnership with NHS West Midlands, WMG and Warwick Medical School (WMS). The IDH aims to improve people's health and wellbeing through the use of innovative digital technologies.
By combining the talents and resources from WMG, WMS, NHS West Midlands, NHS Trusts, private enterprises, charities and other bodies, the IDH will design and deliver appropriate care solutions that will have a real benefit to patients and their care support networks.
Warwick Engineering in Biomedicine
The School of Engineering has a strong reputation for research within the Biomedical Engineering arena. Eleven academic staff work exclusively in biomedical engineering, with a further fourteen in biomedical related fields.
Warwick Engineering in Biomedicine breaks down into 6 core areas of research:
Synthetic Biology is the design of new biological parts, devices and systems, or the redesign of natural biological systems, in order to obtain new, improved or desirable functionality, (e.g., tumor-seeking microbes for cancer treatment). Academics from the School of Engineering are playing a leading role in the development of the Warwick Centre for Integrative Synthetic Biology (WISB) which seeks to bring together academics from across the University to collaborate on projects in this exciting new field.
Medical Sensors and Diagnostics
The development of novel and disruptive sensor technologies that can be applied to the diagnosis and monitoring of diseases is a major strength within the theme– leading to new medical tools that can be deployed to reduce the time to treatment and achieve this at a much lower cost to the medical profession. Important areas are the creation of novel ultra-sound systems, near-infrared imaging and chemical sensors/artificial olfaction. Research activity in this area is extensive, with projects focussing on kidney stones, colon cancer, tuberculosis, liver disease, reproductive medicine and metabolic diseases.
Systems Medicine applies computational or mathematical models and techniques to questions of direct relevance to clinicians. Research in this area at Warwick focusses on a number of different diseases and pathologies, including acute respiratory distress syndrome, chronic obstructive pulmonary disorder, Alzheimer's disease, and cystic fibrosis, in collaboration with clinicians at the Universities of Nottingham and Exeter.
Neural Engineering uses engineering techniques to both understand as well as repair/ enhance neural systems. Information can be extracted, or inferred, from neural systems, from the cellular or ‘whole brain’ level – this information can be used for diagnosis (e.g. Detection of epilepsy), prognosis, communication (e.g. Brain-computer interfacing) or rehabilitation/ assisted living (e.g use of BCI for communication; seizure onset prediction).
Systems Pharmacology is an emerging discipline, which connects systems biology (i.e. genomics, proteomics, and metabolomics) to quantitative pharmacology (i.e. mechanism-based PKPD modelling) to obtain fundamental insights in the interactions between drugs and diseases. It is seen as a novel scientific approach to the design of (complex) therapeutic interventions to modify disease processes.
Nanobioengineering is a new interdisciplinary research paradigm which bridges biomechanics, nanotechnology, biomaterials and cell biology for developing next-generation of therapies and diagnostics. Specifically activity in the area at Warwick focuses on measurement of soft biological materials using advanced techniques such as nanomechanical tester and atomic force microscopy, and the application of nano-biomechanical and nano-manipulation techniques for engineering and characterizing mechanics and adhesions of cell and tissue.
For more information
Specialist academics at Warwick working on this area include: